Literature DB >> 10885786

Disciplining addictions: the bio-politics of methadone and heroin in the United States.

P Bourgois1.   

Abstract

Biomedical understanding of methadone as a magic-bullet pharmacological block to the euphoric effects of heroin is inconsistent with epidemiological and clinical data. An ethnographic perspective on the ways street-based heroin addicts experience methadone reveals the quagmire of power relations that shape drug treatment in the United States. The phenomenon of the methadone clinic is an unhappy compromise between competing discourses: A criminalizing morality versus a medicalizing model of addiction-as-a-brain-disease. Treatment in this context becomes a hostile exercise in disciplining the unruly misuses of pleasure and in controlling economically unproductive bodies. Most of the biomedical and epidemiological research literature on methadone obscures these power dynamics by technocratically debating dosage titrations in a social vacuum. A foucaultian critique of the interplay between power and knowledge might dismiss debates over the Swiss experiments with heroin prescription as merely one more version of biopower disciplining unworthy bodies. Foucault's ill-defined concept of the specific intellectual as someone who confronts power relations on a practical technical level, however, suggests there can be a role for political as well as theoretical engagement with debates in the field of applied substance abuse treatment. Meanwhile, too many heroin addicts who are prescribed methadone in the United States suffer negative side effects that range from an accentuated craving for polydrug abuse to a paralyzing sense of impotence and physical and emotional discomfort.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885786     DOI: 10.1023/a:1005574918294

Source DB:  PubMed          Journal:  Cult Med Psychiatry        ISSN: 0165-005X


  27 in total

1.  Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.

Authors:  H M Rhoades; D Creson; R Elk; J Schmitz; J Grabowski
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

Review 2.  A range of research-based pharmacotherapies for addiction.

Authors:  C P O'Brien
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

3.  Not the picture of health: women on methadone.

Authors:  M Rosenbaum; S Murphy
Journal:  J Psychoactive Drugs       Date:  1987 Apr-Jun

4.  Legal and illegal use of methadone: one year later.

Authors:  R C Stephens; R S Weppner
Journal:  Am J Psychiatry       Date:  1973-12       Impact factor: 18.112

Review 5.  The demedicalization of methadone maintenance.

Authors:  M Rosenbaum
Journal:  J Psychoactive Drugs       Date:  1995 Apr-Jun

6.  An instant shot of "aah": cocaine use among methadone clients.

Authors:  D E Hunt; D L Strug; D S Goldsmith; D S Lipton; B Spunt; L Truitt; K A Robertson
Journal:  J Psychoactive Drugs       Date:  1984 Jul-Sep

7.  Sounding Board. Performance-based rating of methadone maintenance programs.

Authors:  V P Dole; M E Nyswander; D DesJarlais; H Joseph
Journal:  N Engl J Med       Date:  1982-01-21       Impact factor: 91.245

8.  Heroin addiction--a metabolic disease.

Authors:  V P Dole; M E Nyswander
Journal:  Arch Intern Med       Date:  1967-07

Review 9.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

10.  Methadone dosages and therapeutic compliance during a methadone maintenance program.

Authors:  I Maremmani; R Nardini; O Zolesi; P Castrogiovanni
Journal:  Drug Alcohol Depend       Date:  1994-01       Impact factor: 4.492

View more
  61 in total

1.  A tale of two policies: the French connection, methadone, and heroin epidemics.

Authors:  Michael Agar; Heather Schacht Reisinger
Journal:  Cult Med Psychiatry       Date:  2002-09

2.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

3.  Income Generation in Recovering Heroin Users: A Comparative Analysis of Legal and Illegal Earnings.

Authors:  Sarah Callahan; Anthony LoSasso; Bradley Olson; Christopher Beasley; Stephanie Nisle; Kristina Campagna; Leonard A Jason
Journal:  J Offender Rehabil       Date:  2015

4.  The relationship between addiction and religion and its possible implication for care.

Authors:  Laurence Borras; Yasser Khazaal; Riaz Khan; Sylvia Mohr; Yves-Alexandre Kaufmann; Daniele Zullino; Philippe Huguelet
Journal:  Subst Use Misuse       Date:  2010-12       Impact factor: 2.164

5.  Machines, medication, modulation: circuits of dependency and self-care in Las Vegas.

Authors:  Natasha Dow Schüll
Journal:  Cult Med Psychiatry       Date:  2006-06

6.  Why don't out-of-treatment individuals enter methadone treatment programmes?

Authors:  James A Peterson; Robert P Schwartz; Shannon Gwin Mitchell; Heather Schacht Reisinger; Sharon M Kelly; Kevin E O'Grady; Barry S Brown; Michael H Agar
Journal:  Int J Drug Policy       Date:  2008-09-20

7.  "A Résumé for the Baby": Biosocial Precarity and Care of Substance-Using, Pregnant Women in San Francisco.

Authors:  Ashish Premkumar; Jennifer Kerns; Megan J Huchko
Journal:  Cult Med Psychiatry       Date:  2020-03

8.  The biopolitics of needle exchange in the United States.

Authors:  Katherine McLean
Journal:  Crit Public Health       Date:  2011-03-01

9.  Heroin: from drug to ambivalent medicine : on the introduction of medically prescribed heroin and the emergence of a new space for treatment.

Authors:  Birgitte Schepelern Johansen; Katrine Schepelern Johansen
Journal:  Cult Med Psychiatry       Date:  2015-03

10.  Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients.

Authors:  Thu Trang Nguyen; Anh Ngoc Luong; Thi Tuyet Thanh Nham; Carole Chauvin; Jonathan Feelemyer; Nicolas Nagot; Don Des Jarlais; Minh Giang Le; Marie Jauffret-Roustide
Journal:  Int J Drug Policy       Date:  2019-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.